In terms of the biological actions, in 2019, Mani and colleagues revealed that plasma level of LEAP-2 fluctuated in opposite to that of ghrelin according to metabolic status, and was positively correlated with body mass index (BMI) and many metabolic parameters of obesity (10). Here, GHRL is linked to obesity due to melanocortin 4 receptor deficiency.